187 related articles for article (PubMed ID: 20434832)
1. Intracerebral hemorrhage secondary to thrombocytopenia in a patient treated with temozolomide.
Sure D; Dunn I; Norden A; Anderson WS
Clin Neurol Neurosurg; 2010 Oct; 112(8):741-2. PubMed ID: 20434832
[TBL] [Abstract][Full Text] [Related]
2. Therapy for recurrent high-grade gliomas: does continuous dose-intense temozolomide have a role?
Wen PY
J Clin Oncol; 2010 Apr; 28(12):1977-9. PubMed ID: 20308652
[No Abstract] [Full Text] [Related]
3. Combined radiotherapy and temozolomide in patients with recurrent high grade glioma.
Schönekaes K; Mücke R; Panke J; Rama B; Wagner W
Tumori; 2002; 88(1):28-31. PubMed ID: 12004846
[TBL] [Abstract][Full Text] [Related]
4. Factors predicting temozolomide induced clinically significant acute hematologic toxicity in patients with high-grade gliomas: a clinical audit.
Gupta T; Mohanty S; Moiyadi A; Jalali R
Clin Neurol Neurosurg; 2013 Sep; 115(9):1814-9. PubMed ID: 23764039
[TBL] [Abstract][Full Text] [Related]
5. Radiation induced early necrosis in patients with malignant gliomas receiving temozolomide.
Yaman E; Buyukberber S; Benekli M; Oner Y; Coskun U; Akmansu M; Ozturk B; Kaya AO; Uncu D; Yildiz R
Clin Neurol Neurosurg; 2010 Oct; 112(8):662-7. PubMed ID: 20627551
[TBL] [Abstract][Full Text] [Related]
6. Temozolomide in malignant gliomas of childhood: a United Kingdom Children's Cancer Study Group and French Society for Pediatric Oncology Intergroup Study.
Lashford LS; Thiesse P; Jouvet A; Jaspan T; Couanet D; Griffiths PD; Doz F; Ironside J; Robson K; Hobson R; Dugan M; Pearson AD; Vassal G; Frappaz D;
J Clin Oncol; 2002 Dec; 20(24):4684-91. PubMed ID: 12488414
[TBL] [Abstract][Full Text] [Related]
7. Temozolomide: therapeutic limitations in the treatment of adult high-grade gliomas.
Chamberlain MC
Expert Rev Neurother; 2010 Oct; 10(10):1537-44. PubMed ID: 20925470
[TBL] [Abstract][Full Text] [Related]
8. The impact of thrombocytopenia from temozolomide and radiation in newly diagnosed adults with high-grade gliomas.
Gerber DE; Grossman SA; Zeltzman M; Parisi MA; Kleinberg L
Neuro Oncol; 2007 Jan; 9(1):47-52. PubMed ID: 17108062
[TBL] [Abstract][Full Text] [Related]
9. Long-term use of temozolomide: could you use temozolomide safely for life in gliomas?
Khasraw M; Bell D; Wheeler H
J Clin Neurosci; 2009 Jun; 16(6):854-5. PubMed ID: 19303779
[TBL] [Abstract][Full Text] [Related]
10. Radiotherapy followed by adjuvant temozolomide treatment of malignant glioma.
Yang TM; Wang HC; Lin YJ; Lin WC; Lu CH; Chang WN; Chang HW; Ho JT
Surg Neurol; 2008 Dec; 70 Suppl 1():S1:60-3. PubMed ID: 19061770
[TBL] [Abstract][Full Text] [Related]
11. [Recent advances in the medical treatment of glioma-temozolomide].
Nishikawa R
No To Shinkei; 2006 Dec; 58(12):1035-41. PubMed ID: 17193953
[No Abstract] [Full Text] [Related]
12. Temozolomide chemotherapy in patients with recurrent malignant gliomas.
Yang SH; Kim MK; Lee TK; Lee KS; Jeun SS; Park CK; Kang JK; Kim MC; Hong YK
J Korean Med Sci; 2006 Aug; 21(4):739-44. PubMed ID: 16891823
[TBL] [Abstract][Full Text] [Related]
13. Temozolomide: too early for definitive conclusions.
Brown P; Buckner J
J Clin Oncol; 2003 Oct; 21(19):3710. PubMed ID: 14512412
[No Abstract] [Full Text] [Related]
14. High-grade gliomas: results in patients treated with adjuvant radiotherapy alone and with adjuvant radio-chemotherapy.
Valeriani M; Ferretti A; Franzese P; Tombolini V
Anticancer Res; 2006; 26(3B):2429-35. PubMed ID: 16821628
[TBL] [Abstract][Full Text] [Related]
15. Phase I trial of temozolomide using an extended continuous oral schedule.
Brock CS; Newlands ES; Wedge SR; Bower M; Evans H; Colquhoun I; Roddie M; Glaser M; Brampton MH; Rustin GJ
Cancer Res; 1998 Oct; 58(19):4363-7. PubMed ID: 9766665
[TBL] [Abstract][Full Text] [Related]
16. Phase II trial of temozolomide in children with recurrent high-grade glioma.
Ruggiero A; Cefalo G; Garré ML; Massimino M; Colosimo C; Attinà G; Lazzareschi I; Maurizi P; Ridola V; Mazzarella G; Caldarelli M; Di Rocco C; Madon E; Abate ME; Clerico A; Sandri A; Riccardi R
J Neurooncol; 2006 Mar; 77(1):89-94. PubMed ID: 16292488
[TBL] [Abstract][Full Text] [Related]
17. Temozolomide in low-grade gliomas: living longer and better.
Rees J
J Neurol Neurosurg Psychiatry; 2015 Apr; 86(4):359-60. PubMed ID: 25189160
[No Abstract] [Full Text] [Related]
18. Treatment-related myelodysplastic syndrome after temozolomide use in a child: first report.
Dufour C; Da Costa L; Auger N; Jullien M; Bhangoo R; Grill J
J Pediatr Hematol Oncol; 2008 Nov; 30(11):857-9. PubMed ID: 18989164
[TBL] [Abstract][Full Text] [Related]
19. Temozolomide in malignant gliomas: current use and future targets.
Villano JL; Seery TE; Bressler LR
Cancer Chemother Pharmacol; 2009 Sep; 64(4):647-55. PubMed ID: 19543728
[TBL] [Abstract][Full Text] [Related]
20. Toxicity profile of temozolomide in the treatment of 300 malignant glioma patients in Korea.
Bae SH; Park MJ; Lee MM; Kim TM; Lee SH; Cho SY; Kim YH; Kim YJ; Park CK; Kim CY
J Korean Med Sci; 2014 Jul; 29(7):980-4. PubMed ID: 25045231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
